Cash Flow from Operating Activities: A company's cash flows from operations.
Bright Minds Biosciences Inc. (DRUG) had Cash Flow from Operating Activities of $-5.21M for the most recently reported fiscal year, ending 2023-09-30.
| Income Statement Financials | |
-- |
|
$-5.47M |
|
-- |
|
-- |
|
$5.48M |
|
$-5.48M |
|
$0.01M |
|
$-5.47M |
|
$-5.47M |
|
$-5.47M |
|
$-5.47M |
|
$-5.47M |
|
$-5.47M |
|
$-5.48M |
|
$-5.42M |
|
3.72M |
|
3.72M |
|
$-1.47 |
|
$-1.47 |
|
| Balance Sheet Financials | |
$5.05M |
|
-- |
|
$0.05M |
|
$5.10M |
|
$0.21M |
|
-- |
|
-- |
|
$0.21M |
|
$4.89M |
|
$4.89M |
|
$4.89M |
|
3.77M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-5.21M |
-- |
|
$1.62M |
|
$8.62M |
|
$5.00M |
|
$-3.62M |
|
$0.85M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
24.26 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.21M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-111.73% |
|
-111.73% |
|
-107.17% |
|
-111.73% |
|
$1.30 |
|
$-1.40 |
|
$-1.40 |
|